Molecular Biology Program

The John Maciejowski Lab

Research

John Maciejowski, PhD
John Maciejowski, PhD


Associate Professor

The nuclear envelope is a regulated membrane barrier that separates the nucleus from the cytosol in eukaryotes. Although the NE is often depicted as a static barrier, new research has identified conditions where nuclear envelope rupturing causes a loss of compartmentalization. Nuclear envelope ruptures are rapidly repaired in the nucleus, but persist at aberrant, nuclear compartments, such as micronuclei and DNA bridges, that form around mis-segregated chromosomes. Compromised nuclear compartmentalization can result in DNA damage, inflammation, and clustered mutagenesis. The Maciejowski lab seeks to understand how the nuclear envelope safeguards the genome and prevents immune recognition of chromosomal DNA. We approach these problems using a combination of cell biology, biochemistry, and genomics. More information about our research can be found at https://sites.google.com/view/maciejowskilab/home.

Research Projects

Publications Highlights

People

John Maciejowski, PhD

John Maciejowski, PhD



Associate Professor

  • Molecular biologist John Maciejowski studies the causes of complex chromosome rearrangements and the patterns of hypermutation that shape cancer genomes.
  • PhD, Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center
[email protected]
Email Address

Members

Chen Yanyang
Yanyang Chen

Graduate Research Assistant

Alexandra Dananberg
Alexandra Dananberg

Graduate Research Assistant

Amer Azim Hossain

Research Scholar

Adonis C. John

Administrative Assistant

Marton Kovacs
Marton T. Kovacs

Research Fellow

John Maciejowski
John Maciejowski

Assistant Professor, Memorial Sloan Kettering Cancer Center, New York, NY

Taha Mohamed

Research Fellow

Ashley Nichols
Ashley Nichols

Graduate Research Assistant

Roshan Xavier Norman
Roshan Xavier Norman

Research Fellow

Hannah Rosenberg
Hannah Rosenberg

Graduate Research Assistant

Abraham Shim
Abraham Shim

Graduate Research Assistant

Josefine U. Striepen

Graduate Research Assistant

Eleonore Toufektchan
Eleonore Toufektchan

Research Associate

Lab Alumni
Kevan Chu
Kevan Chu

Research Technician

James Hickling
James Hickling

Senior Research Technician

Sara Khalil
Sara Khalil

Graduate Student

Ariel Liberchuk

Research Technician

Lisa Mohr, PhD
Lisa Mohr

Research Fellow

Patrick von Morgen
Patrick von Morgen

Research Associate

Lab Affiliations

Achievements

  • NIH Pathway to Independence Award (2016)
  • Tri-Institutional Breakout Prize for Junior Investigators (2016)
  • Regeneron Prize for Creative Innovation (2016)
  • Pew Biomedical Scholar

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

To learn more about compensation and benefits for postdoctoral researchers at MSK, please visit Resources for Postdocs

Open Positions

Apply now

Get in Touch

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

John Maciejowski discloses the following relationships and financial interests:

  • Merck & Co Inc.
    Intellectual Property Rights

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures